LyophilisedSUR
Survodutide
Bulk≥99.5% Purity
Pharmaceutical-grade survodutide for dual GLP-1/glucagon weight management and liver health research.
Request a Quote
Pricing available for qualified medical professionals, clinics, and distributors.
Enquire NowDownload MonographView FAQMechanism of Action
Survodutide is a dual agonist targeting both GLP-1 and glucagon receptors. GLP-1 activation reduces appetite and promotes satiety, while glucagon activation increases hepatic energy expenditure and promotes lipid oxidation. This combination is being investigated for both weight management and MASH/NASH liver disease.
Clinical Benefits
- Dual GLP-1/glucagon receptor agonism
- Enhanced energy expenditure via glucagon activity
- Supports hepatic lipid metabolism
- Applications in weight management and liver health
Specifications
MechanismDual GLP-1/glucagon agonist
Purity≥99.5%
FormLyophilised powder
Storage & Handling
- Store at 2–8°C
- Protect from light
For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.